Vaccination during pregnancy: Today's need in India

Verma, Ramesh; Khanna, Pardeep; Dhankar, Mukesh

doi:10.1080/21645515.2015.1093265

Cited by 10 publications

(6 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Preventative measures for this disease have long been established with the use of the Tetanus toxoid (TT) vaccine which is one of the most effective and protective against maternal tetanus deaths and has been recommended by WHO in many countries [9]. For this reason, WHO, since 2006, has provided guidelines for the immunization of pregnant women against tetanus [9][10][11][12]. The guidelines require that a pregnant woman receives three doses of tetanus vaccine to protect her and her newborn(s) from tetanus, compared to those whose woman do not receive the vaccine [13].…”

Section: Introductionmentioning

confidence: 99%

Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone

et al. 2020

View full text Add to dashboard Cite

Background: Immunization of women during pregnancy to protect them and their infants against tetanus, pertussis and influenza is recommended by the World health Organization (WHO). However, there is limited information about the coverage rate and associated factors in low-income countries. The aim of this study was to measure the prevalence and predictors of taking tetanus toxoid among pregnant women in Sierra Leone. Methods: This study was based on the fifth round of Multiple Indicator Cluster Survey (MICS 5) conducted in Sierra Leone in 2017. In total 8722 women aged between 15 and 49 years were included in this study. Outcome variable was taking of Tetanus Toxoid vaccination during the last pregnancy. Data were analyzed using cross-tabulation and logistic regression methods. Results: The overall prevalence of receiving TT immunization during women's last pregnancy was 96.3% and that of taking at least two doses was 82.12%. In the regression analysis, women from Mende ethnicity had a 0.48 fold lower chance of being immunized (OR = 0.480, 95% CI = 0.385,0.59768) than those from the other ethnicity. In addition, women who attended at least four ANC visits had higher odds of receiving TT vaccine (OR = 1.919, 95% CI = 1.639, 2.245) compared to those who attended less ANC visits. Stratified by areas, this association was observed in both urban (OR = 2.661, 95% CI = 1.924,3.679) and rural areas (OR = 1.716, 95% CI = 1.430,2.059). Attending at least four ANC visits showed a positive association with receiving at least two doses TT (OR = 2.434, 95% CI = 1.711,3.464) in both urban (OR = 2.815, 95% CI = 1.413,5.610) and rural areas (OR = 2.216, 95% CI = 1.463,3.356) as well. Conclusion: Higher number of ANC visits, mass media exposure and higher wealth quintile increased the odds of receiving TT immunization. In addition, minimum two doses which were identified to reduce neonatal mortality. Therefore, immunization campaigns targeting improved utilization of healthcare and immunization services by women of childbearing age in Sierra Leone are strongly recommended.

show abstract

Section: Introductionmentioning

confidence: 99%

Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone

et al. 2020

View full text Add to dashboard Cite

show abstract

“…The National Immunization Schedule in India recommends the 2 doses of TT for unknown immunization status of pregnant women i.e. the first dose of tetanus toxoid should be administered as soon as pregnancy is detected, and the second dose of TT to be administered after 4 weeks (or second dose could be given 4 weeks prior to the expected dates of pregnancy) and if a mother received 2 TT doses in the last pregnancy and mother gets again pregnant within 3 years then only one dose of TT is recommended and that dose is called booster dose (Verma et al 2016) .…”

Section: Discussionmentioning

confidence: 99%

Maternal health situation in Empowered Action Group of states of India: A comparative analysis of state reports from National Family Health Survey (NFHS)-3 and 4

Roy

Sen

2020

Anthropological Review

View full text Add to dashboard Cite

Motherhood is often claimed as the most positive and fulfilling experience. Nevertheless, there exist several women whose motherhood was associated with suffering, ill-health and even death. The condition is graver in few states of India which are socioeconomically backward (also called Empowered Action Group of states). The present study adopted a narrative description of various key indicators of maternal health as outlined in the NFHS-3 and NFHS-4 state reports. The prime focus was to examine whether the performance of those states has got better or worse in these two survey reports. The study has also discussed various factors related to the performance of each key indicator of maternal health. The overall limiting success of maternal health status in these states calls for improvement in execution of various maternal health related activities.

show abstract

“…Therefore, protective vaccinations against for example COVID-19, influenza or Hepatitis B are intended not only to protect a woman from falling ill but also to protect the developing fetus and ensure its immunity after birth. Their performance became an important global strategy aimed at reduction of mortality and morbidity among pregnant women and developing fetuses, as well as newborns and infants [ 9 – 13 ]. Vaccines should not be withheld among mentioned populations because of pregnancy or breastfeeding but research is always required to determine safety.…”

Section: Introductionmentioning

confidence: 99%

Protective vaccinations during pregnancy - adult Poles knowledge in this area

et al. 2021

View full text Add to dashboard Cite

Background The vaccine is a preparation of biological origin containing antigens that stimulate the body’s immune system to produce acquired immunity. Vaccines can contain killed or “live” (attenuated) microorganisms as well as fragments of these (antigens). Although many vaccines are used routinely in pregnancy to provide a seroprotective immune response for mother, fetus and neonate there is much controversy over their use during this unique time. The aim of the study was to find out about the knowledge of adult Poles on the use of preventive vaccinations during pregnancy. Methods The study involved 700 people (100%) aged 18 to 80 years ($$ \overline{x} $$ x ¯ = 32.16 ± 16.46). Most of the respondents were women (511; 73%). The study consisted of 9 questions about preventive vaccinations of pregnant women and 5 questions about members of the studied group. The aforementioned questions formed the basis of the preparation of the presented article. Results A significant part of respondents (322; 46%) did not have knowledge on the topic of safeness of using preventive vaccinations during pregnancy, 196 (28%) respondents believed that such procedure is not safe. Most of the respondents (371; 53%) did not know about the possibility of using “live” vaccines during pregnancy. 14 (2%) of respondents believed that pregnancy should be terminated in case of administration of a “live” vaccine to a pregnant woman. According to 294 (42%) respondents, vaccinations with “live” vaccines should be completed at least 3 months before the planned pregnancy. The subjects were not aware of the issue of post-exposure vaccination against tetanus and rabies among pregnant women. The respondents’ responses were divided on the issue of the safest trimester of pregnancy for vaccine administration. Almost 1/3 of the respondents (203; 29%) indicated the third trimester as the safest for their performance. Conclusion The knowledge of the surveyed group, the majority of whom were women, about the use of vaccinations before and during pregnancy was unsatisfactory. There is a need to educate the public about the benefits and risks of performing or avoiding preventive vaccinations during pregnancy.

show abstract

Vaccination during pregnancy: Today's need in India

Cited by 10 publications

References 9 publications

Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone

Prevalence and predictors of taking tetanus toxoid vaccine in pregnancy: a cross-sectional study of 8,722 women in Sierra Leone

Maternal health situation in Empowered Action Group of states of India: A comparative analysis of state reports from National Family Health Survey (NFHS)-3 and 4

Protective vaccinations during pregnancy - adult Poles knowledge in this area

Contact Info

Product

Resources

About